A mum from Manchester who was told she only had months to live has now been given the breast cancer all-clear after a groundbreaking drug trial.
51-year-old Jasmin David from Fallowfield was a previously fit and healthy mother of two grown-up children, and was working as a clinical lead at a care home for the elderly, before she discovered that she had an aggressive triple negative form of breast cancer in November 2017 after finding a lump above the nipple.
Following her diagnosis, Jasmin then underwent six months of chemotherapy and a mastectomy in April 2018, followed by 15 cycles of radiotherapy.
These treatments successfully cleared her body of cancer, but sadly, back in October 2019, the cancer returned, and scans showed multiple lesions throughout her body meaning she had a poor prognosis.
Jasmin then discovered that the cancer had unfortunately spread to the lungs, lymph nodes, and chest bone, and was given the devastating news that she had less than a year to live.
ADVERTISEMENT
Two months later, and with no other options left, Jasmin was offered the opportunity to be part of research by participating in the first phase of a two-year groundbreaking clinical trial, which she accepted, and then in December 2019, began treatment at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at The Christie NHS Foundation Trust in Manchester.
Jasmin David is receiving groundbreaking treatment at The Christie NHS Foundation Trust in Manchester / Credit: The Christie NHS Foundation Trust
During the trial, Jasmin is given an experimental medicine combined with Atezolizumab – an immunotherapy drug administered intravenously – which she continues to have every three weeks.
ADVERTISEMENT
Jasmin says she feels “reborn” after beginning the treatment trial.
And she’s now showing no evidence of the disease, and enjoying life with her husband David and children Ryan and Riona.
“I was 15 months down the line after my initial cancer treatment and had almost forgotten about it, but then the cancer returned,” Jasmin explained.
“When I was offered the trial, I didn’t know if it would work for me, but I thought that at least I could do something to help others and use my body for the next generation. At first I had many horrible side effects including headaches and spiking temperatures, so I was in hospital over Christmas and quite poorly – but then thankfully, I started to respond well to the treatment.
"I take each day as a blessing in my life." Jasmin was diagnosed with cancer and given less than a year to live. But she's now been told she's clear of the disease after taking part in a clinical trial.
By June 2021, scans showed no measurable cancer cells in Jasmin’s body and she was then declared cancer free, but will still remain on treatment until December 2023.
Professor Fiona Thistlethwaite, medical oncologist and clinical director of Manchester CRF at The Christie – who is leading on the study in the UK – said: “We are really pleased that Jasmin has had such a good outcome, and at The Christie, we are continually testing new drugs and therapies to see if they can benefit more people.”
The simple hack that can save healthcare workers and teachers money on their holidays
Danny Jones
With cost-of-living pressure ever-present in the background of most everyday lives, finding some spare pennies for a getaway feels more difficult than ever, and if there’s anyone who deserves discounts on a holiday, it’s healthcare workers.
That’s why, when we became aware of the simple hack that can save those working in healthcare services money on holidays, we thought we’d help spread the word.
We’re sure lots of you working within the sector already know plenty about this booking strategy, but for anyone who doesn’t, how do you fancy saving up to half a grand on your next jolly?
In fact, even those working in education can cut their costs, too.
With searches for ‘holiday voucher code’ up by 73% on Google, and even the likes of TikTok seeing ‘money saving tips’ up by 45%, travel agency TUI have decided to team up with the Health Service Discounts platform for 2026.
Providing those who work for the NHS with a ‘Holidays for Heroes’ (HfH) access code on various popular peak-season trips, this exclusive discount can be added on top of all other seasonal TUI deals, including the company’s ‘First Choice’ package holidays.
With the HfH code alone guaranteeing workers an extra £100 off their bookings, play your cards right, and you could get up to £500 in total discounts overall.
How to access the healthcare ‘Holidays for Heroes’ deal
Separate from standard Blue Light card savings, here’s how it works, and don’t worry, it’s all very simple:
As mentioned, education workers can also benefit from similar money off, with an extra £50 per person through the TUI x Discounts for Teachers partnership, as well.
Ella Foden-Lynch, Partnerships Manager for TUI, said in a statement: “Getting away is absolutely vital for wellbeing, especially for those working in high-stress healthcare and education roles.
“With the cost-of-living crisis still putting a strain on household budgets, we know how hard it is to stretch your pay to cover a much-needed family break. By unlocking these exclusive TUI deals, we hope to give our key workers the realistic recovery time they deserve without the financial worry.”
So, for those of you healthcare heroes and teachers looking for a well-deserved break, we urge you to find an affordable holiday that suits you very soon. With cheaper airport pints also inbound later this year, here’s hoping you save even more spends for when you’re away.
New ‘cutting-edge’ cancer treatment to be rolled out on NHS from next week
Emily Sergeant
A new ‘cutting-edge’ cancer treatment is set to be rolled out on the NHS from next week.
Thousands of men with prostate cancer are to be offered high-powered ‘precision’ radiotherapy on the NHS to target the disease more effectively – helping reduce side-effects and spare them 15 courses of treatment.
The highly targeted SABR (stereotactic ablative radiotherapy) delivers radiotherapy to the tumour from many different directions to help reduce the risk of cancer spreading or returning.
SABR has been proven to be effective at far fewer doses than conventional radiotherapy.
Standard radiotherapy can often be a major burden for patients and loved ones, due to the substantial treatment and travel time involved, but SABR is typically delivered in just five doses within a fortnight, compared to at least 20 doses with external beam radiotherapy.
Thousands of men with prostate cancer are to be offered high-powered ‘precision’ radiotherapy on the NHS to target the disease more effectively, helping reduce side-effects and spare them 15 courses of treatment.
Around 17,500 men are diagnosed with low or intermediate risk prostate cancer in England each year and could be offered the option of SABR radiotherapy.
It is expected that the cutting-edge technique for localised prostate cancer will be offered at all 48 radiotherapy providers across England in the coming days – with the first centres making it available on the NHS from next week.
The roll-out could free up around 50,000 appointments for prostate cancer treatment each year, helping the NHS continue to bring down waiting times for patients.
NHS chief executive, Sir Jim Mackey, said the news will ‘transform’ treatment for thousands of men with localised prostate cancer.
“This cutting-edge approach will transform treatment for thousands of men with prostate cancer, helping the NHS provide far more powerful and convenient care to stop their cancer spreading,” Sir Mackey commented.
“Having been proven effective in keeping cancer under control, this technology will not only help reduce the risk of certain side effects but also the major ‘to-and-fro’ burden of hospital treatment, which can be really draining for so many patients and their families.”
Emily Sergeant -
5th July 2022 
